Intra-Cellular Therapies Inc logo

Intra-Cellular Therapies Inc

1
NAS:ITCI (USA)  
$ 51.49 -1 (-1.91%) 04:00 PM EST
P/E:
At Loss
P/B:
8.15
Market Cap:
$ 4.95B
Enterprise V:
$ 4.55B
Volume:
774.02K
Avg Vol (2M):
627.96K
Also Trade In:
Volume:
774.02K
Market Cap $:
4.95B
PE Ratio:
At Loss
Avg Vol (2M):
627.96K
Enterprise Value $:
4.55B
PB Ratio:
8.15

Business Description

Description
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
Name Current Vs Industry Vs History
Cash-To-Debt 28.51
Equity-to-Asset 0.85
Debt-to-Equity 0.03
Debt-to-EBITDA -0.09
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 25.8
Distress
Grey
Safe
Beneish M-Score -1.18
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 32.85
9-Day RSI 34.58
14-Day RSI 35.96
6-1 Month Momentum % 3.16
12-1 Month Momentum % 20.05

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.58
Quick Ratio 7.13
Cash Ratio 5.57
Days Inventory 392.53
Days Sales Outstanding 72.41
Days Payable 141.69

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -19.5
Shareholder Yield % 0.08

Financials (Next Earnings Date:2023-11-03 Est.)

ITCI's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ITCI

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Intra-Cellular Therapies Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 364.162
EPS (TTM) ($) -1.93
Beta 0.4
Volatility % 32.9
14-Day RSI 35.96
14-Day ATR ($) 1.626489
20-Day SMA ($) 55.3535
12-1 Month Momentum % 20.05
52-Week Range ($) 42.01 - 67.05
Shares Outstanding (Mil) 96.09

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Intra-Cellular Therapies Inc Filings

Filing Date Document Date Form
No Filing Data

Intra-Cellular Therapies Inc Stock Events

Event Date Price($)
No Event Data

Intra-Cellular Therapies Inc Frequently Asked Questions

What is Intra-Cellular Therapies Inc(ITCI)'s stock price today?
The current price of ITCI is $51.49. The 52 week high of ITCI is $67.05 and 52 week low is $42.01.
When is next earnings date of Intra-Cellular Therapies Inc(ITCI)?
The next earnings date of Intra-Cellular Therapies Inc(ITCI) is 2023-11-03 Est..
Does Intra-Cellular Therapies Inc(ITCI) pay dividends? If so, how much?
Intra-Cellular Therapies Inc(ITCI) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1